π©Ί BP control helps fight dementia risk
Two Hot Line trials presented at ESC Congress 2026 show promise for high BP and high triglycerides. The CHRCP trial found that intensive BP lowering reduced dementia incidence by 15% in China. Meanwhile, SHASTA-3/4 trials across 24 countries showed plozasiran cut triglycerides by about 80%. This indicates community care can prevent dementia, and plozasiran is a strong therapy for severe hypertriglyceridemia. These results point to better management strategies for related cardiovascular risks. π©Ί